← Back to patent-cliff list
阿托伐他汀钙/雷米普利
Tier C — Watch / tradeAtorvastatin Calcium Hydrate/Ramipril
印度瑞迪博士实验室有限公司
Originator
2008
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：ACE、HMGCR
Brand：Atocor-R
Indications (approved)：高胆固醇血症、高血压
Regional status
US
-
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Atorvastatin Calcium Hydrate/Ramipril?
Approved indications include: 高胆固醇血症, 高血压.
When does the Atorvastatin Calcium Hydrate/Ramipril patent expire?
No public expiry year is available for Atorvastatin Calcium Hydrate/Ramipril yet; this page updates once verified.
How do I get a quote for Atorvastatin Calcium Hydrate/Ramipril intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24